Cerebral metastasis from ovarian carcinoma

Minerva Ginecologica

Volumn 51, Issue 1-2, 1999, Pages 35-37

  Cervoni, L ^a   Gagliardi, F M ^a  

^a NONE

Author keywords

Brain neoplasms secondary; Carcinoma secondary; Ovarian neoplasms

Indexed keywords

ADENOCARCINOMA; ARTICLE; BRAIN TUMOR; CANCER STAGING; CASE REPORT; FATALITY; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVARIECTOMY; OVARY TUMOR; PATHOLOGY;

ADENOCARCINOMA, PAPILLARY; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY;

EID: 0032610667     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Delarive J, Tribolet N, Métastases cérébrales. Etude d'un collectif chirurgical de 81 cas. Neurochirurgie 1992;38:89-97.
2. Rodriguez GC, Soper JT, Berchuck A, Oleson J, Dodge R, Montana G et al Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery. J Clin Oncol 1992;10:1553-60.
3. Duuplat J, Hacker NF, Nieberg RK, Berek JS, Rose TP, Sagae S. Distant metastases in epithelial ovarian cancer. Cancer 1987;60: 1561-6.
4. Piura B, Glezerman M, Galper Y, Segal S, Cohen Y. Brain metastases in epithelial ovarian cancer: two case reports. Eur J Obstet Gynecol Reprod Biol 1990;36:203-8.
5. Redmen J, Hakes T, Gaisio P. Cyclophosphamide, adriamycin and cisplatinum (CAP) treatment of advanced ovariat carcinoma. Proc Am Soc Clin Oncol 1995;4:122-6.
6. Barker GH, Orleoge J, Wilshaw E. Involvement of the central nervous system in patients with ovarian carcinoma. Br J Obstet Gynecol 1981;88:690-4.
7. Larson D, Copeland L, Moser R, Malone J, Gershenson D, Wharton J. Central nervous system in patients with ovarian carcinoma. Obstet Gynecol 1986;68:746-50.
8. Aiba T, Koyama M, Watanalbe T, Miyazawa N, Brain metastasis of ovarian cancer treated by chemotherapy including cisplatinum: a case report. No Shinkei Geka 1989;17:159-61.
9. Dauplat J, Nieberg RK, Hacker NF. Central nervous system metastases in epithelial ovarian carcinoma. Cancer 1987;58:2066-9.
10. Deutsch M, Beck D. Manor D, Brandes J. Metastatic tumor following negative second look operation in ovarian carcinoma, Gynecol Oncol 1987;27:116-20.
11. Dvortsky PM, Richards K, Angel C, Rabinowitz L, Beschman J, Bonfiglio T. Survival time, causes of death and tumor/treatment related morbidity in 100 women with ovarian cancer. Hum Pathol 1988;19:1273-9.
12. Le Roux PD, Berger MS, Elliott P, Tamimi HK. Cerebral metastases from ovarian carcinoma. Cancer 1991;67:2194-9.
13. Mayer RJ, Berkowitz R, Griffiths T. Central nervous system involvment by ovarian carcinoma: a complication of prolonged survival with metastatic disease. Cancer 1978;41:776-83.
14. Negretti E, Zambetti M, Luciani L, Gianni W. Timing of surgery and the role of cytoreductive chemotherapy in patients with advanced ovarian carcinoma. Tumori 1988;74:565-72.
15. Ross WM, Carmichael VA, Shelly WE. Advanced carcinoma of the ovary with central nervous system relapse. Gynecol Oncol 1988;30:398-406.
16. Salvati M, Cervoni L. Solitary cerebral metastasis from ovarian carcinoma: report of 4 cases. J Neurooncol 1994;19:75-7.
17. Ziegler J, Gliedman P, Fass D, Beckman M, Neophytides A, Steinfeld A. Brain metastasis from ovarian cancer. J Neurooncol 1987;5:211-5.
18. De Witte O, Lefranc F, Salmon I, Violon P, Brotchi J. Métastases cérébrales d'origine gynécologique. Neurochirurgie 1996;42:216-20.
19. Griffin TW, Rasey JS, Bleyer WA. The effect of photon irradiation on blood brain barrier permeability to methotrexate in mice. Cancer 1977; 40:1109-11.